Advisors Preferred’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Advisors Preferred’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-28,245	Closed	-$2.16M	–	259
2015 Q1	$2.16M	Buy	28,245 +1,876	+7%	+$138K	1.14%	28
2014 Q4	$1.75M	Buy	+26,369	New	+$1.76M	0.82%	42
2014 Q3	–	Sell	-31,601	Closed	-$1.93M	–	335
2014 Q2	$1.93M	Buy	31,601 +16,887	+115%	+$979K	0.98%	38
2014 Q1	$834K	Sell	14,714 -9,973	-40%	-$566K	0.38%	77
2013 Q4	$1.32M	Buy	+24,687	New	+$1.24M	0.73%	41

Other funds holding PJP

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return

NCM

Niemann Capital Management Stateline, Nevada $788K AUM 23.27% 1-Year Est. Return

FIG

FundX Investment Group San Francisco, California $411M AUM 22.05% 1-Year Est. Return

Advisors Preferred's PJP Position: Q2 2015 in Review

Advisors Preferred sold out of Invesco Pharmaceuticals ETF (PJP) in Q2 2015, closing a stake of 28,245 shares — an estimated $2.16M sold.

Advisors Preferred first reported a position in PJP in Q4 2013 and held it in 5 quarters. The position peaked at $2.16M in Q1 2015. 110 funds tracked by Wall St. Rank hold PJP as of Q2 2015.

Advisors Preferred reported no remaining Invesco Pharmaceuticals ETF position as of Q2 2015 after selling out during the quarter.
Advisors Preferred sold 28,245 Invesco Pharmaceuticals ETF shares in Q2 2015, an estimated $2.16M.
Advisors Preferred first reported a position in Invesco Pharmaceuticals ETF in Q4 2013 and held it in 5 quarters.
Advisors Preferred's Invesco Pharmaceuticals ETF position peaked at $2.16M in Q1 2015.
110 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2015.

Based on Advisors Preferred's 13F filing for Q2 2015, filed 31 Jul 2015.